AVEIR Leadless Pacemaker (LP) UK Registry

Research summary

AVEIR LP UK Registry is a study collecting data from patients who need to have a leadless pacemaker inserted due to underlying heart diseases. Leadless pacemaker technology promises to revolutionise care of the patients that require pacing. The AVEIR pacemaker is the newest of approved leadless pacemakers. Vigilant surveillance of its use in real clinical practice with respect to the effectiveness and safety of the device, at the time of the procedure as well as in the long-term, is essential to ensure that patients receive the best care.The focus is on the data related to the characteristics of the patients that need this type of pacemaker, the reasons why the pacemaker was chosen by the clinical care teams, the safety and efficacy of the device. We plan to recruit and consent 300 patients over 24 months and follow them up for 5 years.

Principal Investigator

Dr Kim Rajappan

Contact us

Email: oxfordheartresearch@ouh.nhs.uk

IRAS number

340241